The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer. 1994

E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
Division of Urology, University of Colorado Health Sciences Center, Denver.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009919 Orchiectomy The surgical removal of one or both testicles. Castration, Male,Orchidectomy,Castrations, Male,Male Castration,Male Castrations,Orchidectomies,Orchiectomies
D010148 Pain, Intractable Persistent pain that is refractory to some or all forms of treatment. Refractory Pain,Intractable Pain,Intractable Pains,Pain, Refractory,Pains, Intractable,Pains, Refractory,Refractory Pains
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
October 1995, European journal of nuclear medicine,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
October 1997, European journal of nuclear medicine,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
March 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
January 1986, Journal of the National Medical Association,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
March 1992, Clinical oncology (Royal College of Radiologists (Great Britain)),
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
February 2003, Medical and pediatric oncology,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
January 1998, The American journal of hospice & palliative care,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
March 2010, Zhonghua nan ke xue = National journal of andrology,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
February 1994, American journal of clinical oncology,
E D Crawford, and J M Kozlowski, and F M Debruyne, and W R Fair, and C J Logothetis, and C Balmer, and R G Robinson, and A T Porter, and D Kirk
January 1988, Acta oncologica (Stockholm, Sweden),
Copied contents to your clipboard!